Metropolitan Life Insurance Company (MetLife)’s Pulmonx LUNG Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,017	Closed	-$18.7K	–	1208
2024 Q1	$18.7K	Sell	2,017 -596	-23%	-$6.99K	﹤0.01%	1891
2023 Q4	$33.3K	Hold	2,613	–	–	﹤0.01%	1649
2023 Q3	$27K	Buy	2,613 +586	+29%	+$6.79K	﹤0.01%	1741
2023 Q2	$26.6K	Hold	2,027	–	–	﹤0.01%	1781
2023 Q1	$22.7K	Sell	2,027 -169	-8%	-$1.67K	﹤0.01%	1822
2022 Q4	$18.5K	Hold	2,196	–	–	﹤0.01%	2058
2022 Q3	$36.6K	Hold	2,196	–	–	﹤0.01%	1670
2022 Q2	$32.3K	Buy	2,196 +396	+22%	+$8.16K	﹤0.01%	1774
2022 Q1	$44.7K	Sell	1,800 -5,828	-76%	-$151K	﹤0.01%	1659
2021 Q4	$245K	Hold	7,628	–	–	﹤0.01%	1882
2021 Q3	$274K	Hold	7,628	–	–	﹤0.01%	1843
2021 Q2	$337K	Buy	7,628 +3,903	+105%	+$170K	﹤0.01%	1776
2021 Q1	$170K	Hold	3,725	–	–	﹤0.01%	2134
2020 Q4	$257K	Buy	+3,725	New	+$182K	﹤0.01%	1773

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s LUNG Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 2,017 shares — an estimated $18.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LUNG in Q4 2020 and held it in 14 quarters. The position peaked at $337K in Q2 2021. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,017 Pulmonx shares in Q2 2024, an estimated $18.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Pulmonx in Q4 2020 and held it in 14 quarters.
Metropolitan Life Insurance Company (MetLife)'s Pulmonx position peaked at $337K in Q2 2021.
111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.